These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 24273730)

  • 41. Diffusion Kurtosis Imaging for Detection of Early Brain Changes in Parkinson's Disease.
    Guan J; Ma X; Geng Y; Qi D; Shen Y; Shen Z; Chen Y; Wu E; Wu R
    Front Neurol; 2019; 10():1285. PubMed ID: 31920913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Alterations of mean diffusivity in brain white matter and deep gray matter in Parkinson's disease.
    Kim HJ; Kim SJ; Kim HS; Choi CG; Kim N; Han S; Jang EH; Chung SJ; Lee CS
    Neurosci Lett; 2013 Aug; 550():64-8. PubMed ID: 23831353
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transcallosal diffusion tensor abnormalities in predominant gait disorder parkinsonism.
    Chan LL; Ng KM; Rumpel H; Fook-Chong S; Li HH; Tan EK
    Parkinsonism Relat Disord; 2014 Jan; 20(1):53-9. PubMed ID: 24126023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Magnetic resonance imaging markers of Parkinson's disease nigrostriatal signature.
    Péran P; Cherubini A; Assogna F; Piras F; Quattrocchi C; Peppe A; Celsis P; Rascol O; Démonet JF; Stefani A; Pierantozzi M; Pontieri FE; Caltagirone C; Spalletta G; Sabatini U
    Brain; 2010 Nov; 133(11):3423-33. PubMed ID: 20736190
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of White Matter Lesions in Parkinson's Disease: Voxel-based Analysis and Tract-based Spatial Statistics Analysis of Parkinson's Disease with Mild Cognitive Impairment.
    Pu W; Shen X; Huang M; Li Z; Zeng X; Wang R; Shen G; Yu H
    Curr Neurovasc Res; 2020; 17(4):480-486. PubMed ID: 32875986
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Parkinson's disease: diffusion kurtosis imaging and the correlation with clinical manifestations].
    Sun YQ; Zhang Q; Jiang Z; Zhang CY; Zhang JW; Chen H; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3534-3537. PubMed ID: 29275590
    [No Abstract]   [Full Text] [Related]  

  • 47. A meta-analysis of diffusion tensor imaging of substantia nigra in patients with Parkinson's disease.
    Deng XY; Wang L; Yang TT; Li R; Yu G
    Sci Rep; 2018 Feb; 8(1):2941. PubMed ID: 29440768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the diagnostic performances of diffusion parameters in diffusion weighted imaging and diffusion tensor imaging of breast lesions.
    Cakir O; Arslan A; Inan N; Anık Y; Sarısoy T; Gumustas S; Akansel G
    Eur J Radiol; 2013 Dec; 82(12):e801-6. PubMed ID: 24099642
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of analytic techniques on comparing DTI-derived measurements in early stage Parkinson's disease.
    Mishra VR; Sreenivasan KR; Zhuang X; Yang Z; Cordes D; Walsh RR
    Heliyon; 2019 Apr; 5(4):e01481. PubMed ID: 31008407
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Altered cerebral perfusion and microstructure in advanced Parkinson's disease and their associations with clinical features.
    Liu Z; Zhang Y; Wang H; Xu D; You H; Zuo Z; Feng F
    Neurol Res; 2022 Jan; 44(1):47-56. PubMed ID: 34313185
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.
    Pyatigorskaya N; Gaurav R; Arnaldi D; Leu-Semenescu S; Yahia-Cherif L; Valabregue R; Vidailhet M; Arnulf I; Lehéricy S
    Sleep; 2017 Nov; 40(11):. PubMed ID: 28958075
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nigral MRI features of asymptomatic welders.
    Lee EY; Flynn MR; Du G; Lewis MM; Goldenberg M; Kong L; Mailman RB; Hong YS; Huang X
    Parkinsonism Relat Disord; 2021 Apr; 85():37-43. PubMed ID: 33691274
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease.
    Vaillancourt DE; Spraker MB; Prodoehl J; Abraham I; Corcos DM; Zhou XJ; Comella CL; Little DM
    Neurology; 2009 Apr; 72(16):1378-84. PubMed ID: 19129507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Imaging nigral pathology and clinical progression in Parkinson's disease.
    Du G; Lewis MM; Sen S; Wang J; Shaffer ML; Styner M; Yang QX; Huang X
    Mov Disord; 2012 Nov; 27(13):1636-43. PubMed ID: 23008179
    [TBL] [Abstract][Full Text] [Related]  

  • 55. White matter structural connectivity is associated with sensorimotor function in stroke survivors.
    Kalinosky BT; Schindler-Ivens S; Schmit BD
    Neuroimage Clin; 2013; 2():767-81. PubMed ID: 24179827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Time course study of fractional anisotropy in the substantia nigra of a parkinsonian rat model induced by 6-OHDA.
    Zhang W; Zhang L; Liu L; Wang X
    Behav Brain Res; 2017 Jun; 328():130-137. PubMed ID: 28390876
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
    Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
    J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson's Disease.
    Fu KA; Nathan R; Dinov ID; Li J; Toga AW
    Front Neurol; 2016; 7():174. PubMed ID: 27812347
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study.
    Stebbins GT; Smith CA; Bartt RE; Kessler HA; Adeyemi OM; Martin E; Cox JL; Bammer R; Moseley ME
    J Acquir Immune Defic Syndr; 2007 Dec; 46(5):564-73. PubMed ID: 18193498
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
    Esterhammer R; Seppi K; Reiter E; Pinter B; Mueller C; Kremser C; Zitzelsberger T; Nocker M; Scherfler C; Poewe W; Schocke M
    PLoS One; 2015; 10(12):e0145493. PubMed ID: 26713760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.